Cancer Cell International

Table 3 DFS-related DEAS events for HP⁻ GC patients

From: Systematic profiling of alternative splicing in Helicobacter pylori-negative gastric cancer and their clinical significance

Gene	Type	ID	Coef	HR	95% CI	P value
POLM	RI	79446	2.321	10.186	2.266–45.797	0.002
PLCD1	AP	64008	− 1.566	0.209	0.057–0.771	0.019
C9orf156	AP	87024	3.492	32.849	1.576–684.536	0.024
ELMOD3	RI	54213	2.629	13.856	1.331–144.215	0.028
TCF12	ES	30789	− 6.138	0.002	0.000–0.043	0.000
SYBU	AP	84909	− 4.891	0.008	0.000–0.179	0.002
ZFYVE21	ES	29513	11.239	76,054.320	322.567–17,931,942.782	0.000

DFS disease-free survival, DEAS differently expressed alternative splicing, HP⁻GC Helicobacter pylori-negative gastric cancer, RI retained intron, AP alternate promoter, ES exon skip, HR hazard ratio, CI confidence interval

Back to article page

ISSN: 1475-2867

Contact us

General enquiries: journalsubmissions@springernature.com